Home Information for Patients Who can enroll in these trials?

Wondering if you're eligible?

Myrexis, Inc. is testing a new agent for the treatment of brain cancer.

If you would like to learn more about our ongoing clinical trials, please contact us.

Who can enroll in these trials? PDF Print

Patients who are over 18 years of age and have brain cancer that has relapsed after initial treatment with surgery, radiation or chemotherapies may be eligible for this study.  To learn more about this study and the types of patients being entered into the trials, please contact us.